Skip to main content
. 2026 Jan 22;27:15. doi: 10.1186/s12865-025-00794-5

Table 2.

Fine-Gray Competing Risk Regression Analysis of Factors Associated with II–IV0 aGVHD

Characteristic Univariable Multivariable
sHR (95% CI) p-value sHR (95% CI) p-value
MDSCs(units/kg)
 ≤33.3 reference reference
 >33.3 0.38 (0.19 -0.75) 0.006 0.71 (0.21 -2.46) 0.590
M-MDSC (units/kg)
 ≤7 reference reference
 >7 0.55 (0.29 -1.05) 0.071 0.84 (0.31 -2.31) 0.730
PMN-MDSCs(units/kg)
 ≤17.5 reference reference
 >17.5 0.43 (0.22 -0.85) 0.014 0.25 (0.07 -0.88) 0.039
LOX1+PMN-MDSCs(units/kg)
 ≤2.5 reference reference
 >2.5 0.56 (0.29 -1.09) 0.086 1.16 (0.46 -2.92) 0.750
MDSCs (%)
 ≤5 reference reference
 >5 0.53 (0.28 -1.03) 0.060 0.92 (0.36 -2.35) 0.850
M-MDSCs (%)
 ≤1 reference reference
 >1 0.54 (0.27 -1.04) 0.066 0.96 (0.31 -2.96) 0.940
PMN-MDSCs (%)
 ≤3 reference
 >3 0.64 (0.34 -1.24) 0.187
LOX+PMN-MDSCs (%)
 ≤16 reference
 >16 1.53 (0.80 -2.94) 0.198
MDSCs absolute count,/μL
 ≤14000 reference reference
 >14000 0.47 (0.24 -0.92) 0.027 0.92 (0.21 -4.11) 0.910
M-MDSCs absolute count,/μL
 ≤2600 reference reference
 >2600 0.42 (0.21 -0.82) 0.012 0.28 (0.10 -0.78) 0.015
PMN-MDSCs absolute count,/μL
 ≤8000 reference reference
 >8000 0.55 (0.29 -1.06) 0.074 0.59 (0.30 -1.21) 0.150
LOX1+PMN-MDSCs absolute count,/μL
 ≤900 reference
 >900 0.83 (0.44 -1.57) 0.571
Gender
 Female reference
 Male 0.59 (0.30 -1.15) 0.120
Age,years
 ≤18 reference reference
 >18 0.48 (0.25 -0.93) 0.029 0.54 (0.26 -1.15) 0.110
2nd HSCT
 No reference
 Yes 0.59 (0.18 -1.93) 0.380
Disease status pre-HSCT
 CR reference
 PR/NR 0.64 (0.25 -1.66) 0.360
HSCT type
 Related donors reference reference
 Unrelated donors 0.42 (0.13 -1.34) 0.140 0.64 (0.13 -3.04) 0.570
Donor type
 HID reference reference
 MSD 0.40 (0.13 -1.24) 0.110 0.33 (0.09 -1.27) 0.110
MNC ×108/kg
 ≤6 reference
 >6 1.30 (0.68 -2.49) 0.420
CD34 ×106/kg
 ≤4 reference reference
 >4 1.30 (0.68 -2.49) 0.091 0.70 (0.33 -1.48) 0.350

sHR subdistribution hazard ratio